A trimeric RBD protein as a booster vaccine enhanced the humoral response and broad neutralization against SARS-CoV-2 in mice

Xiujing HONG; Yangyang HU; Kangli CAO; Longfei DING; Nan GAO; Xiangwei WANG; Chen ZHAO; Xiaoyan ZHANG; Jianqing XU.
Chinese Journal of Microbiology and Immunology ; (12): 837-844, 2022.
Artículo en Zh | WPRIM | ID: wpr-958265

Documentos relacionados

  1. A novel consensus-based computational pipeline for screening of antibody therapeutics for efficacy against SARS-CoV-2 variants of concern including Omicron variant.
  2. Infection with wild-type SARS-CoV-2 elicits broadly neutralizing and protective antibodies against omicron subvariants.
  3. Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift.
  4. Trivalent mRNA Vaccine against SARS-CoV-2 and Variants with Effective Immunization.
  5. Subunit vaccine raised against the SARS-CoV-2 spike of Delta and Omicron variants.
  6. Circular RNA vaccines against SARS-CoV-2 and emerging variants.
  7. Protective prototype-Beta and Delta-Omicron chimeric RBD-dimer vaccines against SARS-CoV-2.
  8. Neutralizing monoclonal antibodies elicited by mosaic RBD nanoparticles bind conserved sarbecovirus epitopes.
  9. Neutralization of SARS-CoV-2 requires antibodies against conformational receptor-binding domain epitopes.
  10. Broad humoral immunity generated in mice by a formulation composed of two antigens from the Delta variant of SARS-CoV-2.